Literature DB >> 18632702

Cellular repair of CNS disorders: an immunological perspective.

Zhiguo Chen1, Theo D Palmer.   

Abstract

Cellular repair is a promising strategy for treating central nervous system (CNS) disorders. Several strategies have been contemplated including replacement of neurons or glia that have been lost due to injury or disease, use of cellular grafts to modify or augment the functions of remaining neurons and/or use of cellular grafts to protect neural tissue by local delivery of growth or trophic factors. Depending on the specific disease target, there may be one or many cell types that could be considered for therapy. In each case, an additional variable must be considered--the role of the immune system in both the injury process itself and in the response to incoming cells. Cellular transplants can be roughly categorized into autografts, allografts and xenografts. Despite the immunological privilege of the CNS, allografts and xenografts can elicit activation of the innate and adaptive immune system. In this article, we evaluate the various effects that immune cells and signals may have on the survival, proliferation, differentiation and migration/integration of transplanted cells in therapeutic approaches to CNS injury and disease.

Entities:  

Mesh:

Year:  2008        PMID: 18632702     DOI: 10.1093/hmg/ddn104

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

1.  Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors.

Authors:  Chao Sheng; Qinyuan Zheng; Jianyu Wu; Zhen Xu; Libin Wang; Wei Li; Haijiang Zhang; Xiao-Yang Zhao; Lei Liu; Ziwei Wang; Changlong Guo; Hua-Jun Wu; Zhonghua Liu; Liu Wang; Shigang He; Xiu-Jie Wang; Zhiguo Chen; Qi Zhou
Journal:  Cell Res       Date:  2011-11-08       Impact factor: 25.617

Review 2.  Immune influence on adult neural stem cell regulation and function.

Authors:  Pamela A Carpentier; Theo D Palmer
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

3.  Survival of neural progenitors allografted into the CNS of immunocompetent recipients is highly dependent on transplantation site.

Authors:  M Janowski; C Engels; M Gorelik; A Lyczek; S Bernard; J W M Bulte; P Walczak
Journal:  Cell Transplant       Date:  2013-01-02       Impact factor: 4.064

4.  Co-transplantation of syngeneic mesenchymal stem cells improves survival of allogeneic glial-restricted precursors in mouse brain.

Authors:  Amit K Srivastava; Camille A Bulte; Irina Shats; Piotr Walczak; Jeff W M Bulte
Journal:  Exp Neurol       Date:  2015-10-26       Impact factor: 5.330

Review 5.  Cell Therapy for Parkinson's Disease: New Hope from Reprogramming Technologies.

Authors:  Zhiguo Chen
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

Review 6.  Stem cells for ischemic brain injury: a critical review.

Authors:  Terry C Burns; Catherine M Verfaillie; Walter C Low
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

Review 7.  Cell migration in the normal and pathological postnatal mammalian brain.

Authors:  Myriam Cayre; Peter Canoll; James E Goldman
Journal:  Prog Neurobiol       Date:  2009-02-11       Impact factor: 11.685

8.  Differential roles of TNFR1 and TNFR2 signaling in adult hippocampal neurogenesis.

Authors:  Zhiguo Chen; Theo D Palmer
Journal:  Brain Behav Immun       Date:  2013-02-09       Impact factor: 7.217

Review 9.  CD 4+ T cells in the pathobiology of neurodegenerative disorders.

Authors:  Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-05-12       Impact factor: 3.478

10.  Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis.

Authors:  Jason G Weinger; Warren C Plaisted; Sonia M Maciejewski; Lewis L Lanier; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.